Диссертация (1174291), страница 26
Текст из файла (страница 26)
Huang, P.C. Lee, M.S. Lee // J. Antimicrob.Chemother. – 2009. – Vol. 64, N 2. – Р. 392-397.188.Huang, R. Culture-negative periprosthetic joint infection does no t precludeinfection control / R. Huang, C.C. Hu, B. Adeli [et al.] // Clin. Orthop. Relat. Res. –2012. – Vol. 470, N 10. – Р. 2717-2723.189.Huddleston, J.I. Hylamer vs conventional polyethylene in primary total hiparthroplasty: a long-term case-control study of wear rates and osteolysis / J.I.Huddleston, A.H.S.
Harris, C.A. Atienza, S.T. Woolson // J. Arthroplasty. – 2009. –Vol. 25, N 2. – P. 203-207.190.Hudec, T. Resection hip arthroplasty – mid- and long-term results / T.Hudec, D. Jahoda, A. Sosna // Acta Chir. Orthop. Traumatol. Cech. – 2005. – Vol. 72,N 5. – Р. 287-292.191.Hwang, B.H. Fungal peri-prosthetic joint in fection after primary total kneereplacement / B.H. Hwang, J.Y. Yoon, C.H. Nam [et al.] // J.
Bone Joint Surg. – 2012. –Vol. 94-B, N 5. – P. 656-659.192.Incavo, S.J. Initial results of managing severe bone loss in infected totaljoint arthroplasty using customized articulating spacers / S.J. Incavo, R.D. Russell, K.B.Mathis, H. Adams // J. Arthroplasty. – 2009. – Vol.
24, N 4. – Р. 607-613.165193.Iorio, R. Diabetes mellitus, hemoglobin A1C, and the incidence of totaljoint arthroplasty infection / R. Iorio, K.M. Williams, A.J. Marcantonio [et al.] // J.Arthroplasty. – 2012. – Vol. 27, N 5. – P. 726-729.194.Jameson, S.S. Wound complications following rivaroxaban administrationa multicenter comparison with low-molecular-weight heparins for thromboprophylaxisin lower limb arthroplasty / S.S.
Jameson, M. Rymaszewska, P. James [et al.] //J. BoneJoint Surg. – 2012. – Vol. 94-A, N 17. – P. 1554-1558.195.John, A.K. Ef ficacy of daptomycin in implant-associated infection due tomethicillin-resistant Staphylococcus aureus: importance of combination with rifampin /A.K. John, D. Baldoni, M. Haschke [et al.] // Antimicrob. Agents Chemother.
– 2009. –Vol. 53, N 7. – P. 2719-2724.196.Joulie, D. Factors governing the healing of Staphylococcus aureusinfections following hip and knee prosthesis implantation: A retrospective study of 95patients / D. Joulie, O. Mares, E. Beltrand [et al.] // Orthop. Traumatol. Surg. Res. –2011. – Vol. 97, N 7 – P.
685-692.197.Kelm, J. Vacuum-assisted closure in the treatment of early hip jointinfections / J. Kelm, E. Schmitt, K. Anagnostakos // Int. J. Med. Sci. – 2009. – Vol. 6,N 5. – P. 241-246.198.Khatod, M. Risk factors for total hip arthroplasty aseptic revision / M.Khatod, G. Cafri, R.S. Namba [et al.] // J. Arthroplasty. – 2014. – Vol. 29, N 7. – P.1412 – 1417.199.Kim, Y.H. Cementless revision for infected total hip replacements / Y.H.Kim, J.S.
Kim, J.W. Park, J.H. Joo // J. Bone Joint Surg. Br. – 2011. – Vol. 93, N 1. –Р. 19-26.200.Kim, Y.H. Influence of patient-, design-, an d surgery-related fa ctors onrate of dislocation after primary cementless total hip arthroplasty / Y.H. Kim, Y. Choi,J.S. Kim // J. Arthroplasty. – 2009. – Vol. 24, N 8. – P. 1258-1263.201.Kliushin, N.M. Modified Girdlestone arthroplasty and hip arthrodesis us ingthe Ilizarov external fixator as a salvage method in the management of severely in fected166total hip replacement / N.M. Kliushin, Y.V.
Ababkov, A.M. Ermakov, T.A. Malkova //Indian J. Orthop. – 2016. – Vol. 50, N 1. – P. 16-25.202.Kobayashi, N. Use of F-18 fluoride PET to differentiate septic from asepticloosening in total hip arthroplasty patients / N. Kobayashi, Y. Inaba, H. Choe [et al.] //Clin. Nucl. Med. – 2011. – Vol. 36, N 1 1 – P. 156-161.203.Konopka, J.F. Risk assessment tools used to predict outcomes of total hipan d total knee arthroplasty / J.F.
Konopka, V.J. Hansen, H.E. Rubash, A.A. Freiberg //Orthop. Clin. North. Am. – 2015. – Vol. 46, N 3. – P. 351-362.204.Koo, K.H. Impregnation of vancomycin, gentamicin, and cefotaxime in acement spacer for t o-stage cementless reconstruction in infected total hip ar throplasty /K.H. Koo, J.W. Yang, S.H. Cho [et al.] // J. Arthroplasty. – 2001. – Vol. 16, N 7. – P.882-892.205.Kose, N. A Silver ion-doped calcium phosphate-based ceramicnanopowder-coated prosthesis increased infection resistance / N.
Kose, A. Otuzbir, C.Peksen [et al.] // Clin. Orthop. Relat. Res. – 2013. – Vol. 471, N 8 – P. 2532-2539.206.Kramer, A. Octenidine, Chlorhexidine, Iodine and Iodophores : Preprint. –Georg Thieme Verlag KG, 2008 – 85 p.207.Krych, A.J. Total hip arthroplasty with shortening subtrochantericosteotomy in Crowe type IV developmental dysplasia / A.J. Krych, J.L. Howard, R.T.Trousdale [et al.] // J. Bo ne Jo int Surg.
– 2009. – Vol. 92-A, N 9. – P. 22 13-2221.208.Kuo, A. Total hip arthroplasty in rapidly destructive osteoarthritis of thehip: a case series / A. Kuo, K.A. Ezzet, S. Patil [et al.] // HSS J. – 2009. – Vol. 5, N 2 –P. 117-119.209.Kurtz, S. Pr ojections of pr imary an d revision hip and knee ar throplasty inthe United States from 2005 to 2030 / S.
Kurtz, K. Ong, E. Lau [et al.] // J. Bone Jo intSurg. – 2007. – Vol. 89-A, N 4. – P. 780-785.210.Lai, K. Presence of medical in patients with infected primary hip or kneearthroplasties / K. Lai, E.R. Bohm, C. Burnell, D.R. Hedden // J. Ar throplasty – 2007. –Vol. 22, N 5. – P.651–656.167211.Lazarinis, S. Increased risk of revision of acetabular cups coated withhydroxyapatite / S. Lazarinis, J. Kärrholm, N.P. Hailer // Acta Orthop. – 2010. – Vol.81, N 1 – P.
53-59.212.Lee, G.C. Total knee ar throplasty after prior bone or joint sepsis ab out theknee / G.C. Lee, M.W. Pagnano, A.D. Hanssen // Clin. Orthop. Relat. Res. – 2002. –N 404. – Р. 226-231.213.Lee, P.T.H. Structural allograft as an option for treating infected hiparthroplasty with massive bone loss / P.T.H.
Lee, R.A. Clayton, O.A. Safir [et al.] //Clin. Orthop. Relat. Res. – 2011. – Vol. 469, N 4. – Р. 1016-1023.214.Lehner, B. First experiences with negative pressure wound therapy andinstillation in the treatment of infected orthopaedic implants: a clinical observational study / B. Lehner, W. Fleischmann, R. Becker, G.N.
Jukema // Int. Orthop. – 2011. – Vol.35, N 9. – P. 1415-1420.215.Leonard, H. Single- or two-stage re vision for infected total hip arthroplastyA systematic review of the li terature / H. Leonard, A.D. Liddle, Ó. Burke [et al.] // Clin.Orthop. Relat. Res. – 2014. – Vol. 472, N 3.
– Р. 1036-1042.216.Levine, B.R. Use of the extended trochanteric osteotomy in treatingprosthetic hip infection / B.R. Levine, C.J. Della Valle, M. Hamming [et al.] //J. Arthroplasty. – 2009. –Vol. 24, N 1. – Р. 49-55.217.Lexer, E. Über Gelenktrasportation / E. Lexer // Med. Klin. Berlin. – 1908.– Bd. 4. – S. 817.218.Lin, P.C. The blood-saving effect of tranexamic acid in minimally invasivetotal knee replacement: is an additional pre-operative in jection effective / P.C. Lin, C.H.Hsu, C.C. Huang [et al.] // J. Bone Joint Surg.
– 2012. – Vol. 94-B, N 7. – P. 932-936.219.Lohmann, C.H. The treatment of periprosthetic infections / C.H. Lohmann,M. Fürst, O. Niggemeyer, W. Rüther // Z. Rheumatol. – 2007. – Bd. 66, H. 1. – S. 2833.220.Lowry, O.H. Protein measurement with Folin phenol reagent / O.H. Lowry,N.J. Rosebrough, A.L. Farr, R.J. Randall // J. Biol. Chem. – 1951. – Vol. 193, N 1. – P.265-275.168221.Lübbeke, A. Influence of obesity on femoral osteolysis five and ten yearsfollowing total hip ar throplasty / A. Lübbeke, G.
Garavaglia, C. Barea [et al.] // J. BoneJoint Surg. – 2010. – Vol. 92-A, N 10. – P. 19 64-1972.222.Mader J.T. In Vitro Evaluation of Antibiotic Diffusion from Antibiotic-Impregnated Biodegradable Beads and Polymethylmethacrylate Beads / J.T. Mader, J.Calhoun, J.Cobos // Antimicrob. Agents Chemother. – 1997. – Vol. 41, N 2. – P. 415418.223.Ma llory, T.H. Preparation of the proximal femur in cementless total hiprevision / T.H.
Mallory // Clin. Orthop. Relat. Res. – 1988. – N 235. – Р. 47-60.224.Manoharan, V. Closed incision negative pressure wound therapy versusconventional dry dressings following primary knee arthroplasty: a randomisedcontrolled study / V. Manoharan, A. Grant, A. Harris [et al.] // J. Arthroplasty.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
